Technology
Researchers engineer “Nanotraps” that block SARS-CoV-2 infection – News-Medical.Net
Researchers at Chicago University have developed an innovative new anti-SARS-CoV-2 therapy called “Nanotraps” – a family of nano-enabled virus-trapping particles…
It is well known that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of the coronavirus disease 2019 (COVID-19) pandemic, invades the human host cell through its spike protein. This protein engages with the angiotensin-converting enzyme 2 (ACE2) receptors on the human cell, enabling the virus to infiltrate and hijack its metabolic mechanisms for the purposes of viral replication.
A new nanomedicine, called “Nanotraps” – a family of nano-enabled virus-trapping…
-
General23 hours agoFederal Labor makes $100m Canberra convention centre funding pledge for planning, new aquatic centre
-
Business9 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
General19 hours agoTribute unveiled for SA Police Brevet Sergeant Jason Doig after fatal 2023 shooting
-
Noosa News4 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred